2023
Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence
Wang Y, Daar E, Huang Y, Xiong D, Shen J, Zhou L, Siqueiros L, Guerrero M, Rosen M, Liu H. Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption – Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence. AIDS And Behavior 2023, 27: 4041-4051. PMID: 37401993, PMCID: PMC10598162, DOI: 10.1007/s10461-023-04118-9.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Retroviral AgentsCommunicable Disease ControlCOVID-19HIV InfectionsHumansMedication AdherencePandemicsViral LoadConceptsLog viral loadViral loadClinical trialsHIV RNA viral loadUsual care groupHIV viral suppressionRNA viral loadRandomized clinical trialsSelf-reported adherenceLongitudinal mixed effects modelsViral suppressionClinical outcomesCare groupWeek 28Week 16Intervention groupAntiretroviralsIntervention effectsVulnerable populationsAdherenceMixed effects modelsRandom interceptRetention rateCOVID-19 pandemicIngestible sensor
2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial
Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage G, Guerrero M, Corado K, Rosen M, Fletcher C, Daar E. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine 2022, 86: 104330. PMID: 36372731, PMCID: PMC9782816, DOI: 10.1016/j.ebiom.2022.104330.Peer-Reviewed Original ResearchConceptsHIV RNA viral loadRNA viral loadViral loadARV concentrationsUC groupIngestible sensorUsual care groupIngestible Sensor SystemOverall satisfaction rateInstitute of HealthGroup-based trajectory modelsAdvancing Translational SciencesAntiretroviral therapyHIV clinicCare groupText remindersIS groupImproved adherenceMeasure scoresSatisfaction rateStudy participantsAntiretroviralsMental healthAdherenceNational Institute
2012
Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14
Rosen MI, Black AC, Arnsten JH, Goggin K, Remien RH, Simoni JM, Golin CE, Bangsberg DR, Liu H. Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14. AIDS And Behavior 2012, 17: 142-147. PMID: 22246513, PMCID: PMC3549004, DOI: 10.1007/s10461-011-0124-7.Peer-Reviewed Original Research
2000
Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention
Rigsby M, Rosen M, Beauvais J, Cramer J, Rainey P, O'Malley S, Dieckhaus K, Rounsaville B. Cue‐dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention. Journal Of General Internal Medicine 2000, 15: 841-847. PMID: 11119180, PMCID: PMC1495713, DOI: 10.1046/j.1525-1497.2000.00127.x.Peer-Reviewed Original ResearchConceptsCue-dose trainingAntiretroviral therapy regimensTherapy regimensAdherence interventionsVeterans Affairs HIV clinicsBottle openingPilot studyActive training periodAntiretroviral Adherence InterventionClinical trial sitesNear-baseline levelsAfrican AmericansHistory of heroinTraining periodAntiretroviral therapyHIV clinicMedication takingAntiretroviral drugsClinical studiesPill bottlesCD groupTransient improvementSustained improvementControl groupCocaine use